Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Lemaitre Vascular (LMAT) EBIAT (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed EBIAT for 16 consecutive years, with $15.6 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 39.32% to $15.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $57.7 million, a 31.1% increase, with the full-year FY2025 number at $57.7 million, up 31.1% from a year prior.
  • EBIAT was $15.6 million for Q4 2025 at Lemaitre Vascular, down from $17.4 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $17.4 million in Q3 2025 to a low of -$28.9 million in Q4 2023.
  • A 5-year average of $7.1 million and a median of $7.8 million in 2023 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: crashed 613.44% in 2023, then skyrocketed 138.71% in 2024.
  • Lemaitre Vascular's EBIAT stood at $6.2 million in 2021, then dropped by 8.87% to $5.6 million in 2022, then plummeted by 613.44% to -$28.9 million in 2023, then surged by 138.71% to $11.2 million in 2024, then soared by 39.32% to $15.6 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's EBIAT are $15.6 million (Q4 2025), $17.4 million (Q3 2025), and $13.8 million (Q2 2025).